Related Experiment Video
Updated: May 29, 2026

11:21
Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
A novel radiofrequency ablation catheter using contact force sensing: Toccata study
Karl-Heinz Kuck1, Vivek Y Reddy, Boris Schmidt
1Abt. Kardiologie, Asklepios Klinik St. Georg, Hamburg, Germany. kuckkh@asklepios.com
Heart Rhythm
|August 30, 2011
Summary
This study shows that radiofrequency (RF) ablation using a novel force-sensing catheter is safe for treating supraventricular tachycardia (SVT) and atrial fibrillation (AF). Real-time contact force (CF) monitoring offers valuable insights for safe catheter manipulation during cardiac ablation procedures.
Area of Science:
- Cardiology
- Medical Devices
- Electrophysiology
Background:
- Radiofrequency (RF) ablation is used for cardiac arrhythmias.
- Contact force (CF) between catheter tip and tissue impacts RF ablation outcomes.
- Both insufficient and excessive CF can lead to ineffective treatment or complications.
Purpose of the Study:
- To evaluate the safety of a novel force-sensing RF ablation catheter.
- To assess device- and procedure-related safety during real-time CF measurement.
- To present CF data and its implications for patient safety in cardiac ablation.
Main Methods:
- A multicenter study involving 77 patients undergoing percutaneous ablation.
- Patients had either supraventricular tachycardia (SVT) or atrial fibrillation (AF).
- A novel catheter measuring real-time contact force (CF) was used, with CF and safety events recorded.
Main Results:
- CF values varied significantly between investigators during mapping.
- High transient CFs (>100 g) were observed in a significant portion of patients in the AF group.
- One device-related complication (tamponade) occurred in the AF group (3%).
Conclusions:
- Catheter ablation with real-time CF technology is safe for SVT and AF treatment.
- CF monitoring provides crucial information for safe catheter manipulation.
- Future CF-sensing catheters may enhance RF ablation effectiveness by improving lesion size control.

